- Meeting abstract
- Open Access
Morinda citrifolia l. treatments (noni) reduce glycemia in the model of aloxan-induced diabetes in rats
- José Bégue Moreira de Carvalho1Email author,
- Glauce Socorro Barros Viana1,
- José Galberto Martins da Costa1,
- Thyciara Fontenele Marques1,
- Alisson Cordeiro Moreira1,
- Úrsula Tavares de Sousa1,
- João Victor Rodrigues Lacerda1,
- Enaide Soares Santos1,
- Ítalo Cordeiro Moreira1,
- Maria Janice Pereira Lopes1 and
- Maria Neyrilane Torquato de Souza1
© de Carvalho et al. 2015
- Published: 11 November 2015
- Diabetes Mellitus
- Blood Glucose
Diabetes mellitus is a chronic disease characterized by hyperglycemia which Results from alterations in secretion or insulin action. There is a large number of studies searching for natural products potentially hypoglycemic and presenting a low risk of adverse effects.
To evaluate the effects of the hydro-alcoholic extract of fruits from M. citrifolia on the glycemic profile in rats.
Alloxan (40 mg/kg, iv) was injected in male Wistar rats (250 g) and after 48 h, animals were subjected to blood collection for measurements of blood glucose (mg/dL). Only those showing glycemia levels higher than 250 mg/dL were submitted to the study. The animals were daily administered with 100 and 500 mg/kg of the Noni extract (N100 e N500), 120 mg/kg Metformin (M120) and 120 mg/kg Metformin + 100 mg/kg Noni extract (M120+N100), orally for 1 month. After this period, animals were subjected to another blood collection for blood glucose determination. The untreated diabetic controls (DC) received saline for the same period. For statistical analysis, ANOVA and the Newmam-Keuls (post hoc test) were used for multiple comparisons. Whenever needed the Student “t” test was used for means comparison before and after treatments. The differences were considered significant at p<0.05.
The N100 and N500 groups reduced blood glucose by 63 and 70%, respectively, as related to glycemia levels before treatments (N100: n=7, before: 406,4±31,16; post-treatment: 149.7±47.57 and N500: n=9, before: 462.4±24.82; post-treatment: 136.7±22.6), while the M120, M120+N100 and DC groups showed decreases of blood glucose of only 28, 19 and 17%, respectively (M120: n=12, before: 319.8±12.27; post-treatment: 231.1±31.4; M120+N100: n=6, before: 343.0±20.21; post-treatment: 277,4±32,13 and DC: n=9, before: 411,4±15,79; post-treatment: 341.9±28.4).
The repeated administration of the hydro-alcoholic extract from the fruits of Morinda citrifolia promoted a significant reduction in blood glucose, after 1 month at the doses 100 and 500 mg/kg, a result not observed after metformin, used as reference. Furthermore, no synergism was presented by the association of Noni extract with metformin, suggesting that Noni exerts its effects by a different mechanism of action. The chemical study of the extract revealed the presence, among others, of phenols in great concentrations and those may be, at least partly, responsible for the observed effects.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.